Northwestern to Co-Lead New Chan Zuckerberg Biohub

The Chan Zuckerberg Initiative (CZI) has selected Northwestern University to co-lead its new biomedical research hub in Chicago, which will develop new technologies for studying human tissues with unprecedented resolution. The hub’s ultimate goal is to unite the region’s best researchers to improve understanding of inflammation, potentially leading to new treatments for the inflammatory conditions that underlie disease.

Northwestern will co-lead the Chan Zuckerberg Biohub Chicago (CZ Biohub Chicago) with the University of Chicago and the University of Illinois, Urbana-Champaign. Shana O. Kelley, the Neena B. Schwartz Professor of Chemistry and Biomedical Engineering at Northwestern, will serve as the hub’s president.

“We’re thrilled to be part of the Chan Zuckerberg Biohub Network, which will galvanize multidisciplinary research and drive more progress than any one of these institutions could have achieved on its own,” Kelley said. “The scientific challenge we’re exploring has large engineering challenges to surmount, and is wildly, but not impossibly, ambitious — and can only be solved by interdisciplinary collaboration.”

Kelley is a professor of chemistry at the Weinberg College of Arts and Sciences, professor of biomedical engineering at the McCormick School of Engineering, and professor of biochemistry and molecular genetics at Northwestern University Feinberg School of Medicine.

Learn more in Northwestern Now’s story “Northwestern to co-lead new Chan Zuckerberg Biohub Chicago.”